Evidence map›Paper›PMID 42211877›Full record

ArticleNon-coding RNA research2026

Discovery of a G-rich ultra stable human ncRNA G-quadruplex that binds ATP.

Margaret Bohmer, Kai Jin, Peixuan Guo

Abstract read
In one paragraph

Article in Non-coding RNA research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Margaret BohmerCenter for RNA Nanobiotechnology and Nanomedicine, Center for RNA Biology, Division of Pharmaceutics and Pharmacology, College of Pharmacy, James Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.
Kai JinCenter for RNA Nanobiotechnology and Nanomedicine, Center for RNA Biology, Division of Pharmaceutics and Pharmacology, College of Pharmacy, James Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.
Peixuan GuoCenter for RNA Nanobiotechnology and Nanomedicine, Center for RNA Biology, Division of Pharmaceutics and Pharmacology, College of Pharmacy, James Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thermostable RNA motifs have been shown to be a unique material for building nanoparticles for many applications (Guo lab, Nature Nanotechnology, 2020 PMID: 21102465; 2021 PMID: 21909084). Here, we report the discovery of a G-rich ultra-stable human ncRNA G-quadruplex that binds ATP with a strong potential to become a drug-carrying nanoparticle. Motion is a key feature of living systems, which can be achieved with ATPase biomotors. Humans produce, metabolize, and consume ATP per day in an amount equivalent to their body weight. Due to the abundance of noncoding RNA (ncRNA) discovered in the human body, it is expected that many short or long noncoding RNAs will be involved in ATP binding and hydrolysis. This is based on the fact that, although all currently reported ATPases are proteins, only 1.5% of the human DNA genome codes for proteins, while the remaining 98.5% codes for ncRNAs that play crucial roles in regulating life functions. We discovered an endogenous human ncRNA G-quadruplex that binds ATP. This ATP-binding RNA was discovered via

Indexed as

ATP-Binding RNAG-quadruplexNoncoding RNA

Identifiers

PMID42211877
PMCPMC13213811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.